Xandar Kardian, a Toronto-based healthtech company, has secured $10 million in its Series A funding round from Phoenix Venture Partners, Portfolia Active Aging & Longevity Fund, Taronga Ventures, and other undisclosed investors.
Incorporated in 2017, Xandar Kardian develops contactless health monitoring solutions powered by digital ultra wide-band radar signal processing.
In April, its XK300 Autonomous Health Monitoring Solution was cleared by the U.S. Food and Drug Administration. The system can be used at home or in healthcare facilities to predict health outcomes by monitoring the patient’s resting heart rate and respiratory rate.
Its radar technology can also be implemented to smart buildings, providing commercial and public building operators with real-time occupancy measurements. This system allows for effective energy optimization compared to passive infrared motion sensors.
Xandar Kardian said it has over 23 patents granted with 11 still pending.
Although its operations are based in Canada, its research and development lab is based in Seoul, South Korea. Xandar Kardian also has offices in Chicago and Hartford, Connecticut.
Its research on radar technology began in 2011 with 15 phD candidates. The startup claims it’s the first company to commercialize radar technology in airports, banks, correctional facilities, class A office buildings, shopping malls, long term care facilities, and hospitals.
Xandar Kardian’s past funding includes a $3 million seed round in December 2019, and a $650,000 investment in April 2018, as reported by Crunchbase.
Sam Yang, CEO and co-founder of Xandar Kardian, said its new capital will support the commercial rollout of its healthcare solutions and the expansion of its real estate tech business.
As a serial entrepreneur, Yang has co-founded a number of companies prior to starting Xandar Kardian with James Cho, its chief technology officer. In 2014, Yang became the co-founder of Kairos, a smart watch company. He also led Zenesis Electronics in 2011.
Image from Healthcare IT Today